Evidence map›Paper›PMID 42209451›Full record

ArticleHuman genome variation2026

Carney complex with PRKAR1A variant and breast/fibrolamellar carcinomas.

Abílio Alonso Colares Perez, Laura Pinheiro Correia, Régis Ponte Conrado, Vinícius Nascimento Malheiro, Carlos Gustavo Hirth, Diane Isabelle Magno Cavalcante, Gustavo Rêgo Coelho, Ana Rosa Pinto Quidute, Danielle Calheiros Campelo Maia

Abstract read
In one paragraph

Article in Human genome variation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Abílio Alonso Colares Perez *School of Medicine, Department of Clinical Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil. abilioperez@alu.ufc.br.ORCID http://orcid.org/0009-0004-4896-9889
Laura Pinheiro Correia *School of Medicine, Department of Clinical Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil.
Régis Ponte ConradoSchool of Medicine, Department of Clinical Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0001-6266-0774
Vinícius Nascimento MalheiroSchool of Medicine, Department of Clinical Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0003-3166-243X
Carlos Gustavo HirthFederal University of Ceará, Instituto do Câncer do Ceará Fortaleza, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0002-6610-5660
Diane Isabelle Magno CavalcanteDepartment of Pathology and Legal Medicine, Federal University of Ceará, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0001-7585-0307
Gustavo Rêgo CoelhoDepartment of Surgery, Walter Cantídio University Hospital, Federal University of Ceará, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0003-0845-2864
Ana Rosa Pinto QuiduteDivision of Endocrinology, Walter Cantídio University Hospital, Federal University of Ceará, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0000-0003-1876-6410
Danielle Calheiros Campelo MaiaDepartment of Clinical Oncology, Walter Cantídio University Hospital, Federal University of Ceará, Fortaleza, Ceará, Brazil.ORCID http://orcid.org/0009-0006-9915-0106

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Carney complex is a rare multiple neoplasia syndrome caused primarily by inactivating variants in the PRKAR1A gene, which encodes the regulatory subunit type I alpha of protein kinase A. Although classically associated with myxomas, lentigines, and endocrine tumors, the full tumor spectrum related to PRKAR1A loss of function is not completely defined. Here, we report a patient with a molecularly confirmed diagnosis of Carney complex carrying a de novo PRKAR1A (NM_002734.5):c.348+1G>A splice-site variant. In addition to typical manifestations, the patient developed two uncommon malignancies: invasive breast carcinoma (luminal B-like) at a young age and fibrolamellar hepatocellular carcinoma lacking the DNAJB1-PRKACA fusion typically found in sporadic cases. The coexistence of these two rare tumors in a single carrier of a pathogenic PRKAR1A variant expands the phenotypic variability associated with this condition and supports the possibility that PRKAR1A loss contributes to oncogenesis beyond the classical endocrine and mesenchymal tissues. This Data Report provides clinically relevant documentation of an unusual tumor presentation associated with a pathogenic PRKAR1A variant and underscores the importance of ongoing clinical surveillance in affected individuals.

Identifiers

PMID42209451
PMCPMC13451425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.